Introduction: Nifedipine and cardioprotection Antonio Strano Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 877 - 877
Nifedipine and experimental cardioprotection Winifred Gwen NaylerJianjun LiuSianna Panagiotopoulos Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 879 - 885
Protective effects of pretreatment with intracoronary nifedipine on myocardial ischemia and dysfunction Ivo AmendeGunhild HerrmannPaul R. Lichtlen Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 887 - 891
Increased coronary tone in exertional angina: The beneficial effects of calcium antagonists Giuseppe SpecchiaDiego ArdissinoStefano De Servi Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 893 - 897
The combination of slow-release nifedipine and atenolol for stable angina Derek G. WallerVivian F. Challenor Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 899 - 904
Acute effects of nifedipine versus isosorbide dinitrate on exercise tolerance in patients with isolated coronary artery occlusion and collaterals Francesco BarillàFrancesco PellicciaAttilio Reale Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 905 - 908
Intravenous nifedipine prevents ergonovine-induced myocardial ischemia in patients with stable effort angina Claudio BrunelliPaolo SpallarossaSalvatore Caponnetto Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 909 - 914
Efficacy of slow-release nifedipine on ischemic attacks in patients with variant angina Hirofumi YasueYasuhiro Morikami Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 915 - 918
Effects of nifedipine on cardiac function in patients with coronary artery disease evaluated with ambulatory radionuclide monitoring Hirofumi KambaraI. H. MohiuddinChuuichi Kawai Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 919 - 922
Effects of nifedipine on left venticular diastolic dysfunction after myocardial infarction Roldano ScognamiglioGiuseppe Fasoli Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 923 - 928
Rationale for treatment of silent myocardial ischemia: Focus on nifedipine Richard W. Nesto Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 929 - 934
Use of nifedipine in hypertension and Raynaud's phenomenon W. KiowskiP. ErneF. R. Bühler Nifedipine in Hypertension Pages: 935 - 940
Long-term therapy with slow-release nifedipine in essential hypertension Francesco ArrigoFausto Consolo Nifedipine in Hypertension Pages: 941 - 945
Effects of nifedipine on left ventricular diastolic function in hypertension; Echo Doppler study Giancarlo GambelliElisabetta AmiciAlberto Selvanetti Nifedipine in Hypertension Pages: 951 - 955
Early regression of left ventricular diastolic abnormalities in hypertensive patients treated with nifedipine I. SheibanG. CoviA. Lechi Nifedipine in Hypertension Pages: 957 - 961
Nifedipine interactions in hypertensive patients Antonio SalvettiArmando MagagnaRoberto Giovannetti Nifedipine in Hypertension Pages: 963 - 968
Assessment of left ventricular function after sublingual administration of nifedipine in patients with moderate to severe hypertension Hiroshi HayashiMasatsugu IwaseMitsuhiro Yokota Nifedipine in Hypertension Pages: 969 - 975
Effects of slow-release nifedipine on water-sodium, uric acid, and calcium metabolism, and on aldosterone secretion in patients with essential hypertension Osamu IimuraKazuaki ShimamotoHiroaki Komura Nifedipine in Hypertension Pages: 977 - 977
Renal effects of calcium entry blockers Luis M. RuilopeJose M. Alcazar Nifedipine: Renal Effects Pages: 979 - 982
Effect of nifedipine on urinary excretion of calcium and calcium-controlling hormones in essential hypercalciuria Lorenzo CalóSalvatore CantaroArturo Borsatti Nifedipine: Renal Effects Pages: 983 - 986
Effect of nifedipine administration on pulse wave velocity (PWV) of chronic hemodialysis patients—2-year trial Yasushi SaitoKohji ShiraiSho Yoshida Nifedipine: Renal Effects Pages: 987 - 990
Acute effects of sublingual nifedipine on left ventricular function in hemodialysis hypertensive patients G. BotteroP. MorosettiU. Casciani Nifedipine: Renal Effects Pages: 991 - 992
Pathogenesis of atherosclerosis: State of the art Christian C. Haudenschild Nifedipine and Atherogenesis Pages: 993 - 1004
Excessive mural calcium overload — A predominant causal factor in the development of stenosing coronary plaques in humans A. FleckensteinM. FreyG. Fleckenstein-Grün Nifedipine and Atherogenesis Pages: 1005 - 1013
Antiatherogenic effects of calcium-channel blockers: Possible mechanisms of action Philip D. Henry Nifedipine and Atherogenesis Pages: 1015 - 1020
Quantitative analysis of antiatherosclerotic effect of nifedipine in cholesterol-fed rabbits Yhukou OhtaNaoaki HiguchiToshiaki Sunaga Nifedipine and Atherogenesis Pages: 1021 - 1026
Influence of nifedipine on experimental arteriosclerosis Andreas M. KnorrStanislav Kazda Nifedipine and Atherogenesis Pages: 1027 - 1031
Effects of short- and long-term administration of nifedipine on serum lipoprotein metabolism in patients with mild hypertension Jun SasakiKikuo Arakawa Nifedipine and Atherogenesis Pages: 1033 - 1035
Features of the angiographic evaluation of the INTACT study Stefan JostJaap DeckersINTACT study group Nifedipine and Atherogenesis Pages: 1037 - 1045
Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: Results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy) Paul R. LichtlenPaul G. HugenholtzJaap W. Deckers Nifedipine and Atherogenesis Pages: 1047 - 1068
